Mutations in Cell Cycle Genes in Melanoma
Author Information
Author(s): A Platzl, P Sevigny, T Norberg, P Ring, B Lagerlof, U Ringborg
Primary Institution: Karolinska Hospital
Hypothesis
Are mutations in genes involved in G1 checkpoint control common in human melanoma metastases?
Conclusion
The study found that 44% of melanoma patients had mutations in at least one of the investigated cell cycle genes.
Supporting Evidence
- 44% of patients had mutations in at least one of the investigated genes.
- Mutations were found in CDKN2A, CDKN2B, p53, and N-ras genes.
- Previous studies indicated that alterations in cell cycle genes are common in various tumors.
Takeaway
This study looked at patients with melanoma and found that many had changes in important genes that help control cell growth.
Methodology
The study used mutational analysis by PCR/SSCP and nucleotide sequence analysis on metastases from melanoma patients.
Limitations
The study may not have detected all mutations due to the limitations of the PCR method used.
Participant Demographics
Patients had histologically verified cutaneous malignant melanoma.
Want to read the original?
Access the complete publication on the publisher's website